Abstract
Since 2008, a large epidemic of Rocky Mountain spotted fever has been emerging among humans and dogs in Mexicali, adjacent to the United States in Baja California, Mexico. We molecularly confirmed the causative agent; this information can be used to study the origin and dynamics of the epidemic.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1723-1725 |
| Number of pages | 3 |
| Journal | Emerging Infectious Diseases |
| Volume | 24 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 1 2018 |
Fingerprint
ASJC Scopus subject areas
- Epidemiology
- Microbiology (medical)
- Infectious Diseases
Cite this
Molecular confirmation of rocky mountain spotted fever epidemic agent in Mexicali, Mexico. / Tinoco-Gracia, Luis; Lomelí, Moisés Rodríguez; Hori-Oshima, Sawako; Stephenson, Nicole; Foley, Janet E.
In: Emerging Infectious Diseases, Vol. 24, No. 9, 01.09.2018, p. 1723-1725.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Molecular confirmation of rocky mountain spotted fever epidemic agent in Mexicali, Mexico
AU - Tinoco-Gracia, Luis
AU - Lomelí, Moisés Rodríguez
AU - Hori-Oshima, Sawako
AU - Stephenson, Nicole
AU - Foley, Janet E
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Since 2008, a large epidemic of Rocky Mountain spotted fever has been emerging among humans and dogs in Mexicali, adjacent to the United States in Baja California, Mexico. We molecularly confirmed the causative agent; this information can be used to study the origin and dynamics of the epidemic.
AB - Since 2008, a large epidemic of Rocky Mountain spotted fever has been emerging among humans and dogs in Mexicali, adjacent to the United States in Baja California, Mexico. We molecularly confirmed the causative agent; this information can be used to study the origin and dynamics of the epidemic.
UR - http://www.scopus.com/inward/record.url?scp=85052242154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052242154&partnerID=8YFLogxK
U2 - 10.3201/eid2409.171523
DO - 10.3201/eid2409.171523
M3 - Article
C2 - 30124418
AN - SCOPUS:85052242154
VL - 24
SP - 1723
EP - 1725
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
SN - 1080-6040
IS - 9
ER -